Drug Trial Radar · NCT00808132
Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
Last checked: Nov 19, 2026Latest source record: Apr 8, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,886
Actual
Start
Jan 2009
Primary completion
Feb 2011
Study completion Feb 2011
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Dec 15, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 40 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research study is to evaluate the safety and effectiveness of this investigational drug for the treatment of menopausal symptoms while protecting the endometrium (uterine lining) and preventing postmenopausal osteoporosis. Subject participation will last approximately 14.5 months.
Conditions
- Menopause
- Osteoporosis
Interventions
bazedoxifene 20 mg/ conjugated estrogens 0.45 mgDrug
One capsule, bazedoxifene 20 mg/conjugated estrogens 0.45 mg (over-encapsulated), once a day for one year.
bazedoxifene 20 mg/ conjugated estrogens 0.625 mgDrug
One capsule, bazedoxifene 20 mg/conjugated estrogens 0.625 mg (over-encapsulated), once a day for one year.
bazedoxifene 20 mgDrug
One capsule, bazedoxifene 20 mg (over-encapsulated), once a day for one year.
conjugated estrogens 0.45 mg/ medroxyprogesterone acetate 1.5 mgDrug
One capsule, conjugated estrogens 0.45 mg and medroxyprogesterone 1.5 mg (over-encapsulated), once a day for one year.
PlaceboDrug
One capsule, placebo (over-encapsulated), once a day for one year.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Endometrial Hyperplasia at Month 12: Main StudyTime frame: Month 12
- Percent Change From Baseline in Bone Mineral Density (BMD) of Lumbar Spine at Month 12: Osteoporosis Sub-StudyTime frame: Baseline, Month 12
Locations
178 sites in 12 countries. Site status is shown where the registry gives one.
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Mobile, Alabama
Pfizer Investigational Site
Chandler, Arizona
Pfizer Investigational Site
Glendale, Arizona
Pfizer Investigational Site
Mesa, Arizona
Pfizer Investigational Site
Peoria, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Scottsdale, Arizona
Pfizer Investigational Site
Tucson, Arizona
Pfizer Investigational Site
Tucson, Arizona
Pfizer Investigational Site
Tucson, Arizona
Pfizer Investigational Site
Little Rock, Arkansas
Pfizer Investigational Site
Carmichael, California
Pfizer Investigational Site
Sacramento, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
San Diego, California
Pfizer Investigational Site
Upland, California
Pfizer Investigational Site
Vista, California
Pfizer Investigational Site
Walnut Creek, California
Pfizer Investigational Site
Colorado Springs, Colorado
Pfizer Investigational Site
Colorado Springs, Colorado
Pfizer Investigational Site
Denver, Colorado
Pfizer Investigational Site
Denver, Colorado
Pfizer Investigational Site
Lakewood, Colorado
Pfizer Investigational Site
New London, Connecticut
Pfizer Investigational Site
Boynton Beach, Florida
Pfizer Investigational Site
Clearwater, Florida
Pfizer Investigational Site
Crystal River, Florida
Pfizer Investigational Site
Daytona Beach, Florida
Pfizer Investigational Site
DeLand, Florida
Pfizer Investigational Site
Fort Lauderdale, Florida
Pfizer Investigational Site
Fort Lauderdale, Florida
Pfizer Investigational Site
Fort Myers, Florida
Pfizer Investigational Site
Lake Worth, Florida
Pfizer Investigational Site
Miami, Florida
Pfizer Investigational Site
Miami, Florida
Pfizer Investigational Site
Miami Springs, Florida
Pfizer Investigational Site
New Port Richey, Florida
Pfizer Investigational Site
Pinellas Park, Florida
Showing 40 of 178 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.